{"entity":{"id":"pillar-biosciences","kind":"company","name":"Pillar Biosciences","aka":[],"tldr":"Massachusetts maker of sequencing panels whose ONCO/Reveal Dx assay is an FDA companion diagnostic in bowel and lung cancer.","summary":"Pillar Biosciences makes sequencing panels for solid tumour tissue, liquid biopsy and blood cancers. Its ONCO/Reveal Dx Lung & Colon Cancer Assay was approved by the FDA in July 2021 as a companion diagnostic for KRAS wild-type colorectal cancer (cetuximab, panitumumab) and for EGFR-mutant lung cancer (approved EGFR inhibitors).","asOf":"2026-11-03","links":[{"label":"Official website","url":"https://www.pillarbiosci.com"},{"label":"FDA PMA P200011","url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P200011"}],"tags":[],"related":[],"cancers":["colorectal","nsclc"],"sections":["diagnostics"],"technologies":["companion-diagnostic"],"targets":[],"drugs":["onco-reveal-dx-lung-colon"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Natick, MA","country":"US","companyType":"diagnostics","website":"https://www.pillarbiosci.com","investors":[],"funding":[]},"route":"/companies/pillar-biosciences/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"companion-diagnostic","kind":"technology","name":"Companion diagnostics","route":"/technologies/companion-diagnostic/"}],"drug":[{"id":"onco-reveal-dx-lung-colon","kind":"drug","name":"ONCO/Reveal Dx Lung and Colon Cancer Assay","route":"/drugs/onco-reveal-dx-lung-colon/"}]}}